Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel polo-like kinase inhibitors developed at GSK

Oct. 19, 2004

Ranbaxy scientists describe new iminosugar-based anticancer agents

Oct. 19, 2004

Abarelix demonstrates safety and efficacy in clinical trials

Oct. 18, 2004

Vantas approved for advanced prostate cancer

Oct. 18, 2004

ArQule discovers oral B-RAF kinase inhibitors for oncology

Oct. 18, 2004

Antagonists of denatured collagen type IV and their use as antiangiogenic agents

Oct. 18, 2004

Nucleotide-bisphosphonate conjugates reduce metastatic bone tumor burden in mice

Oct. 18, 2004

Antiangiogenic small molecule inhibits VEGF production in tumors in vivo

Oct. 18, 2004

SB-715992 dose-dependently reduces ANC in patients with solid tumors

Oct. 15, 2004

Oral CP-547632 shows promise in the treatment of advanced solid tumors

Oct. 15, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...
Evaxion shares data from characterization of EVX-04
BioWorld Science
Evaxion A/S has developed EVX-04, an AI-designed DNA vaccine encoding 1β endogenous retroviruses (ERVs)-derived antigenic fragments to induce broad...